文献速递主动脉疾病颈动脉与弓上血管

胸主动脉腔内修复术覆盖左锁骨下动脉与30天卒中高发生率相关:伴或不伴血运重建

Thoracic Endovascular Aortic Repair With Left Subclavian Artery Coverage Is Associated With a High 30-Day Stroke Incidence With or Without Concomitant Revascularization.
PubMed 文献 · J Endovasc Ther · 2020-05-21

基于美国国家外科质量改进计划 registry 2005–2017 年 2346 例非急诊 TEVAR 病例,比较覆盖与不覆盖左锁骨下动脉(LSA)的 30 天卒中发生率。覆盖 LSA 者卒中发生率为 5.2%,不覆盖者为 2.3%(p<0.001);覆盖 LSA 时伴同期血运重建者卒中发生率为 7.5%,不伴者为 4.4%。覆盖 LSA 伴或不伴血运重建均与卒中独立相关,同期血运重建未降低卒中发生率。

要点

  • TEVAR 覆盖 LSA 者 30 天卒中发生率 5.2%,显著高于不覆盖者的 2.3%。
  • 覆盖 LSA 时同期血运重建者卒中发生率 7.5%,不伴血运重建者为 4.4%。
  • 覆盖 LSA 伴血运重建(OR 4.0)或不伴血运重建(OR 2.2)均与卒中独立相关。

核心结论

  • 真实世界中 TEVAR 覆盖 LSA 后卒中发生频繁,同期 LSA 血运重建未降低卒中发生率。

研究设计与样本

  • 基于美国国家外科质量改进计划 registry 2005–2017 年数据,纳入 2346 例非急诊 TEVAR 病例。
  • 比较覆盖 LSA(n=888)与不覆盖 LSA(n=1458)患者的 30 天卒中发生率。
  • 覆盖 LSA 者中比较伴同期 LSA 血运重建(n=228)与不伴者(n=660)。
  • 另分析孤立 LSA 血运重建治疗闭塞性疾病(n=768)的卒中发生情况。
  • 采用多因素 logistic 回归进行风险校正分析。

主要发现

  • 不覆盖 LSA 者卒中发生率为 2.3%,覆盖 LSA 者为 5.2%(p<0.001)。
  • 覆盖 LSA 者中,伴同期血运重建者卒中发生率为 7.5%,不伴者为 4.4%。
  • 孤立 LSA 血运重建者卒中发生率为 0.5%。
  • 33 例发生围手术期卒中的 TEVAR 患者中,8 例(24%)在 30 天内死亡。
  • 覆盖 LSA 伴同期血运重建与卒中的 OR 为 4.0(95%CI 2.2–7.5,p<0.001),不伴血运重建的 OR 为 2.2(95%CI 1.3–3.8,p=0.002)。

临床怎么用

  • TEVAR 需覆盖 LSA 时应充分评估卒中风险,同期 LSA 血运重建未显示降低卒中发生率。
  • 对合并呼吸困难、肾功能不全或 INR≥2.0 的患者,应加强围手术期卒中风险防范。

局限性

  • 本研究为回顾性 registry 分析,可能存在未测量混杂因素。
  • 未报告不同 LSA 血运重建方式(如搭桥、开窗、分支支架)对卒中的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose: To evaluate the perioperative stroke incidence following thoracic endovascular aortic repair (TEVAR) with differing left subclavian artery (LSA) coverage and revascularization approaches in a real-world setting of a nationwide clinical registry. Materials and Methods: The National Surgical Quality Improvement Program registry was interrogated from 2005 to 2017 to identify all nonemergent TEVAR and/or open LSA revascularization procedures. In this time frame, 2346 TEVAR cases met the selection criteria for analysis. The 30-day stroke incidence was compared between patients undergoing TEVAR with (n=888) vs without (n=1458) LSA coverage, for those with (n=228) vs without (n=660) concomitant LSA revascularization among those with coverage, and following isolated LSA revascularization for occlusive disease (n=768). Multivariable logistic regression was employed for risk-adjusted analyses and to identify factors associated with stroke following TEVAR. Results of the regression analyses are presented as the adjusted odds ratio (OR) with 95% confidence interval (CI). Results: The stroke incidence was 2.3% following TEVAR without vs 5.2% with LSA coverage (p<0.001). In TEVARs with LSA coverage, the stroke incidence was 7.5% when the LSA was concomitantly revascularized and 4.4% without concomitant revascularization, while stroke occurred in 0.5% of isolated LSA revascularizations. Of 33 TEVAR patients experiencing a perioperative stroke, 8 (24%) died within 30 days. LSA coverage was associated with stroke both with concomitant revascularization (OR 4.0, 95% CI 2.2 to 7.5, p<0.001) and without concomitant revascularization (OR 2.2, 95% CI 1.3 to 3.8, p=0.002). Other preoperative factors associated with stroke were dyspnea (OR 1.8, 95% CI 1.1 to 3.0, p=0.014), renal dysfunction (OR 2.2, 95% CI 1.0 to 3.8, p=0.049), and international normalized ratio ≥2.0 (OR 3.6, 95% CI 1.0 to 13, p=0.045). Conclusion: Stroke following TEVAR with LSA coverage occurs frequently in the real-world setting, and concurrent LSA revascularization was not associated with a lower stroke incidence.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Varkevisser RRB, Swerdlow NJ, de Guerre LEVM, et al. Thoracic Endovascular Aortic Repair With Left Subclavian Artery Coverage Is Associated With a High 30-Day Stroke Incidence With or Without Concomitant Revascularization. J Endovasc Ther. 2020. PMID: 32436807. doi:10.1177/1526602820923044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。